Low-Entropy Hydration Shells at the Spike RBD’s Binding Site May Reveal the Contagiousness of SARS-CoV-2 Variants

por Yang, Lin, Guo, Shuai, Hou, Chengyu, Jiang, Shenda, Shi, Liping, Ma, Xiaoliang, Zheng, Bing, Fang, Yi, Ye, Lin, He, Xiaodong
Publicado 2023

A thylakoid membrane-bound and redox-active rubredoxin (RBD1) functions in de novo assembly and repair of photosystem II

por García-Cerdán, José G., Furst, Ariel L., McDonald, Kent L., Schünemann, Danja, Francis, Matthew B., Niyogi, Krishna K.
Publicado 2019

Enhancement versus neutralization by SARS-CoV-2 antibodies from a convalescent donor associates with distinct epitopes on the RBD

por Zhou, Yunjiao, Liu, Zezhong, Li, Shibo, Xu, Wei, Zhang, Qianqian, Silva, Israel T., Li, Cheng, Wu, Yanling, Jiang, Qingling, Liu, Zhenmi, Wang, Qiujing, Guo, Yu, Wu, Jianbo, Gu, Chengjian, Cai, Xia, Qu, Di, Mayer, Christian T., Wang, Xiangxi, Jiang, Shibo, Ying, Tianlei, Yuan, Zhenghong, Xie, Youhua, Wen, Yumei, Lu, Lu, Wang, Qiao
Publicado 2021

Seroconversion and Abundance of IgG Antibodies against S1-RBD of SARS-CoV-2 and Neutralizing Activity in the Chilean Population

por González-Stegmaier, R., Cereceda, K., Briones, J. L., Beltran-Pávez, C., Oyarzún-Arrau, A., Riquelme-Barrios, S., Selman, C., Yarad, F., Mahave, M., Caglevic, C., Morales, R., Aguirre, A., Valiente-Echeverría, F., Soto-Rifo, R., Marsiglia, H., Gazitua, R., Villarroel-Espindola, F.
Publicado 2021

Recombinant vaccine containing an RBD-Fc fusion induced protection against SARS-CoV-2 in nonhuman primates and mice

por Sun, Shihui, He, Lei, Zhao, Zhongpeng, Gu, Hongjing, Fang, Xin, Wang, Tiecheng, Yang, Xiaolan, Chen, Shaolong, Deng, Yongqiang, Li, Jiangfan, Zhao, Jian, Li, Liang, Li, Xinwang, He, Peng, Li, Ge, Li, Hao, Zhao, Yuee, Gao, Chunrun, Lang, Xiaoling, Wang, Xin, Fei, Guoqiang, Li, Yan, Geng, Shusheng, Gao, Yuwei, Wei, Wenjin, Hu, Zhongyu, Han, Gencheng, Sun, Yansong
Publicado 2021

A Low-Cost SARS-CoV-2 rRBD ELISA to Detect Serostatus in Ecuadorian Population with COVID-19

por Guevara, Ángel, Vivero, Sandra, Nipaz, Victoria, Guaraca, Victor, Coloma, Josefina
Publicado 2021

A Nanoscaffolded Spike-RBD Vaccine Provides Protection against SARS-CoV-2 with Minimal Anti-Scaffold Response

por Lainšček, Duško, Fink, Tina, Forstnerič, Vida, Hafner-Bratkovič, Iva, Orehek, Sara, Strmšek, Žiga, Manček-Keber, Mateja, Pečan, Peter, Esih, Hana, Malenšek, Špela, Aupič, Jana, Dekleva, Petra, Plaper, Tjaša, Vidmar, Sara, Kadunc, Lucija, Benčina, Mojca, Omersa, Neža, Anderluh, Gregor, Pojer, Florence, Lau, Kelvin, Hacker, David, Correia, Bruno E., Peterhoff, David, Wagner, Ralf, Bergant, Valter, Herrmann, Alexander, Pichlmair, Andreas, Jerala, Roman
Publicado 2021

Germline IGHV3-53-encoded RBD-targeting neutralizing antibodies are commonly present in the antibody repertoires of COVID-19 patients

por Yan, Qihong, He, Ping, Huang, Xiaohan, Luo, Kun, Zhang, Yudi, Yi, Haisu, Wang, Qian, Li, Feng, Hou, Ruitian, Fan, Xiaodi, Li, Pingchao, Liu, Xinglong, Liang, Huan, Deng, Yijun, Chen, Zhaoming, Chen, Yunfei, Mo, Xiaoneng, Feng, Liqiang, Xiong, Xiaoli, Li, Song, Han, Jian, Qu, Linbing, Niu, Xuefeng, Chen, Ling
Publicado 2021

Identification of SARS-CoV-2-against aptamer with high neutralization activity by blocking the RBD domain of spike protein 1

por Yang, Ge, Li, Ziyue, Mohammed, Irfan, Zhao, Liping, Wei, Wei, Xiao, Haihua, Guo, Weisheng, Zhao, Yongxiang, Qu, Feng, Huang, Yuanyu
Publicado 2021

The impact of spike N501Y mutation on neutralizing activity and RBD binding of SARS-CoV-2 convalescent serum

por Lu, Lu, Chu, Allen Wing-Ho, Zhang, Ricky Ruiqi, Chan, Wan-Mui, Ip, Jonathan Daniel, Tsoi, Hoi-Wah, Chen, Lin-lei, Cai, Jian-Piao, Lung, David Christopher, Tam, Anthony Raymond, Yau, Yat-Sun, Kwan, Mike Yat-Wah, To, Wing-Kin, Tsang, Owen Tak-Yin, Lee, Larry Lap-Yip, Yi, Haisu, Ip, Tak-Chuen, Poon, Rosana Wing-Shan, Siu, Gilman Kit-Hang, Mok, Bobo Wing-Yee, Cheng, Vincent Chi-Chung, Chan, Kwok Hung, Yuen, Kwok-Yung, Hung, Ivan Fan-Ngai, To, Kelvin Kai-Wang
Publicado 2021

Characterization of the Diagnostic Performance of a Novel COVID-19 PETIA in Comparison to Four Routine N-, S- and RBD-Antigen Based Immunoassays

por Spaeth, Alexander, Masetto, Thomas, Brehm, Jessica, Wey, Leoni, Kochem, Christian, Brehm, Martin, Peter, Christoph, Grimmler, Matthias
Publicado 2021

Recombinant Protein Expression and Purification of N, S1, and RBD of SARS-CoV-2 from Mammalian Cells and Their Potential Applications

por García-Cordero, Julio, Mendoza-Ramírez, Juvenal, Fernández-Benavides, David, Roa-Velazquez, Daniela, Filisola-Villaseñor, Jessica, Martínez-Frías, Sandra Paola, Sanchez-Salguero, Erik Saul, Miguel-Rodríguez, Carlos E., Maravillas Montero, Jose L., Torres-Ruiz, Jose J., Gómez-Martín, Diana, Argumedo, Leopoldo Santos, Morales-Ríos, Edgar, Alvarado-Orozco, Juan M., Cedillo-Barrón, Leticia
Publicado 2021

Reply to Lassaunière: On the functional characterization of the Y453F RBD variant found in cluster 5 SARS-CoV-2

por Bayarri-Olmos, Rafael, Johnsen, Laust Bruun, Rosbjerg, Anne, Helgstrand, Charlotte, Bak-Thomsen, Theresa, Garred, Peter, Skjoedt, Mikkel-Ole
Publicado 2021

Phosphate-mediated coanchoring of RBD immunogens and molecular adjuvants to alum potentiates humoral immunity against SARS-CoV-2

por Rodrigues, Kristen A., Rodriguez-Aponte, Sergio A., Dalvie, Neil C., Lee, Jeong Hyun, Abraham, Wuhbet, Carnathan, Diane G., Jimenez, Luis E., Ngo, Julia T., Chang, Jason Y. H., Zhang, Zeli, Yu, Jingyou, Chang, Aiquan, Nakao, Catherine, Goodwin, Benjamin, Naranjo, Christopher A., Zhang, Libin, Silva, Murillo, Barouch, Dan H., Silvestri, Guido, Crotty, Shane, Love, J. Christopher, Irvine, Darrell J.
Publicado 2021

Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2

por Han, Pengcheng, Li, Linjie, Liu, Sheng, Wang, Qisheng, Zhang, Di, Xu, Zepeng, Han, Pu, Li, Xiaomei, Peng, Qi, Su, Chao, Huang, Baihan, Li, Dedong, Zhang, Rong, Tian, Mingxiong, Fu, Lutang, Gao, Yuanzhu, Zhao, Xin, Liu, Kefang, Qi, Jianxun, Gao, George F., Wang, Peiyi
Publicado 2022

Amantadine-assembled nanostimulator enhances dimeric RBD antigen-elicited cross-neutralization against SARS-CoV-2 strains

por Zhang, Ye, Wang, Ruixin, He, Chunyan, Zhang, Yu-Fang, Luo, Zhongrui, Luo, Jia, Chen, Sisi, Jin, Yu, Xie, Bowen, Liu, Ye
Publicado 2022

An AAV vaccine targeting the RBD of the SARS-CoV-2 S protein induces effective neutralizing antibody titers in mice and canines

por Liu, Fei, Feng, Canbin, Xu, Shiqi, Wu, Qiang, Tang, Jian, Chen, Yan, Xu, Ruisheng, Chen, Fuliang, Gao, Ni, Xu, Zhengzheng, Gu, Shihui, Lan, Yang, Zhou, Haibo, Hu, Xinde, Wang, Xiaojing
Publicado 2022

A SARS-CoV-2 nanobody that can bind to the RBD region may be used for treatment in COVID-19 in animals

por Wu, Peng, Yang, Qin, Zhao, Xiaoli, Liu, Qingqing, Xi, Jing, Zhang, Fan, He, Jinke, Yang, Hang, Zhang, Chao, Ma, Zhongchen, Deng, Xiaoyu, Wang, Yong, Chen, Chuangfu
Publicado 2022

RBD trimer mRNA vaccine elicits broad and protective immune responses against SARS-CoV-2 variants

por Liang, Qingtai, Wang, Yifeng, Zhang, Shuyuan, Sun, Jing, Sun, Wenbo, Li, Jizhou, Liu, Yaping, Li, Mingxi, Cheng, Lin, Jiang, Yuhang, Wang, Ruoke, Zhang, Rui, Yang, Zihan, Ren, Yifei, Chen, Peng, Gao, Peng, Yan, Huayuan, Zhang, Zheng, Zhang, Qi, Shi, Xuanling, Wang, Jianbin, Liu, Wanli, Wang, Xinquan, Ying, Bo, Zhao, Jincun, Qi, Hai, Zhang, Linqi
Publicado 2022

Novel Synthetic Lipopeptides as Potential Mucosal Adjuvants Enhanced SARS-CoV-2 rRBD-Induced Immune Response

por Mao, Ling, Liu, Chang, Liu, Jing-Yi, Jin, Zi-Li, Jin, Zhe, Xue, Ruo-Yi, Feng, Rang, Li, Guo-Cheng, Deng, Yan, Cheng, Hao, Zou, Quan-Ming, Li, Hai-Bo
Publicado 2022